AMGEN (AMGN) has a profit margin of 24.14%, above the Healthcare sector average of 17.63%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
The latest profit margin for AMGN is 24.14% as of September 2026. That compares with 19.48% in the prior-year period — up 23.9% year over year. That is above the Healthcare sector average of 17.63%. Investors often review this figure alongside AMGEN's historical trend and sector peers before judging valuation or financial health.
Over the past year, AMGN's profit margin moved from 19.48% to 24.14% — a 23.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in AMGEN's valuation or profitability profile.
Against Healthcare companies, AMGN currently prints 24.14% for profit margin, while the sector average sits near 17.63%. That is roughly 36.9% above the sector mean. Large gaps often invite a closer look at AMGEN's growth, margins, and balance sheet.
Profit Margin shows how effectively AMGEN converts resources into returns. At 24.14%, AMGN may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 19.48% in the prior-year period — up 23.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting AMGN's profit margin (24.14%), review year-over-year change from 19.48%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.